Commercial porcine gastric mucin contributes to variation in production of small molecule virulence factors by Pseudomonas aeruginosa when cultured in different formulations of artificial sputum medium
Abstract
Site-specific in vitro culture media are being developed to investigate microbial pathogenicity and ecology in nutrient environments that are more reflective of disease. For microbial ecology research in cystic fibrosis (CF), different artificial sputum media (ASM) formulations have been created to recapitulate the nutrient availability of the CF lung environment. However, these ASM formulations vary in concentration of amino acids, mucin, and other niche-specific compounds. Here, we measured the differential production of small molecule virulence factors by Pseudomonas aeruginosa, the predominant pathogen in CF pulmonary infections, cultured in nine different ASM formulations via liquid chromatography tandem mass spectrometry (LC-MS/MS) and molecular networking. We show that different ASM formulations lead to different phenotypes and metabolic profiles of P. aeruginosa and commercial porcine gastric mucin (PGM) contains a myriad of contaminants, including iron, which affect P. aeruginosa physiology. IMPORTANCEDifferent media formulations aiming to replicate in vivo infection environments contain different nutrients, which affects interpretation of experimental results. Inclusion of undefined components, such as commercial porcine gastric mucin (PGM), in an otherwise chemically defined medium can alter the nutrient content of the medium in unexpected ways and influence experimental outcomes.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Host- and microbial-mediated mucin degradation differentially shape Pseudomonas aeruginosa physiology and gene expression
Sabrina J. Arif, Kayla M. Hoffman, … Ryan C. Hunter·PLoS PathogensPeer-reviewed·Oct 3, 2025
- Iron content of commercial mucin contributes to compositional stability of a cystic fibrosis airway synthetic microbiota community
Emily Giedraitis, Rachel L. Neve, Vanessa V. Phelan·bioRxiv·Sep 6, 2024
- Genome-wide survey of Pseudomonas aeruginosa PA14 reveals a role for the glyoxylate pathway and extracellular proteases in the limited utilization of mucin
J. M. Flynn, C. Q. Phan, R. C. Hunter·bioRxiv·Dec 4, 2016
- Growing Staphylococcus aureus in Synthetic Cystic Fibrosis Medium Promotes Colonization in a Murine Pneumonia Model
Justin M. Luu, Ian N. Moore, … Joanna B. Goldberg·Infection and ImmunityPeer-reviewed·Aug 6, 2026
- Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease
Jeffrey M Flynn, David Niccum, … Ryan C Hunter·PLOS PathogensPeer-reviewed·Aug 22, 2016
- Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production
J. Scott, K. Li, … G. O'Toole·bioRxiv·Jan 4, 2019